Peli BioThermal, the global name in temperature-controlled packaging, will highlight how selecting the right packaging helps companies achieve sustainability objectives. They will share expertise and knowledge on sustainability as guest speakers at Clinical Trial Supply Europe, being held in Madrid on March 11 – 12, 2020.
Peli BioThermal will also be hosting roundtable discussions on thermal packaging’s contribution to sustainability in the clinical trial sector alongside exhibiting the company’s high performance shippers for clinical trial applications including; CoolPall™ Flex, Crēdo™ Cube, CoolGuard™ PCM and CoolGuard™ Advance.
Paul Terry, Peli BioThermal’s Director of Sales EMEA, is a key speaker at the annual event which sees delegates from Europe’s largest pharmaceutical companies and biotech innovators congregate to discuss the latest trends in clinical supply chain innovation.
He will host a presentation entitled: Sustainability – contributing to your objectives with your temperature controlled packaging,which will shine a spotlight on issues including:
- The use of reusable packaging with regards to sustainability
- The impact of temperature controlled packaging in the waste and recycling streams
- How choosing the right temperature controlled packaging can support your sustainability programme
Paul Terry said: “Sustainability is increasingly an area of focus across the industry and worldwide. Our reusable shippers and flexible rental program options help clinical trial and life sciences companies to address sustainability issues.
“The clinical trial sector is an area of significant growth for Peli BioThermal and we welcome the opportunity to exhibit our award-winning thermal packaging solutions and services at the conference. With more than 100 network stations and drop points globally, our resuable shipper solutions continue to lead the way when it comes to driving for greater sustainability throughout supply chains worldwide.”
Exhibiting at Stand 12 at CTS Europe, Peli BioThermal will showcase its services and temperature controlled shippers for clinical trials applications demonstrating how these can help achieve sustainability objectives within the growing biopharma industry.
